Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of ...

In the summer of 2024, the downtrend in obesity drug stocks started. Lilly (LLY) fell from around $1000 to below $700. By ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

We recently published 11 Stocks Jim Cramer Shared His Insights On. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim ...

Eli Lilly’s market capitalisation hit the $1tn mark in the past week, becoming the first healthcare company in the world to ...

Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding ...

Just in time for the holiday season, Lilly unveiled its multi-pronged campaign to tie in Alzheimer’s awareness with cultural ...

Eli Lilly, the drugmaker company’s valuation has soared to $1 trillion as the demand grows due to the weight-loss boom. This ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

In the last part of November 2025, Eli Lilly and Company shattered a historic ceiling. The Indianapolis-based drugmaker became the first pharmaceutical company to reach a market capitalization of $1 ...

The remarkable achievement means that its largest shareholder, the Lilly Endowment, now holds assets worth approximately $102 billion as of Tuesday afternoon trading in New York. The foundation owns ...

Retail traders ranked Novo Nordisk as the strongest long-term obesity play in a 1,100-vote poll. Users pointed to emerging ...